BlackRock Institutional Trust’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $2.96M | Buy |
276,656
+37,424
| +16% | +$400K | ﹤0.01% | 2912 |
|
|
2016
Q3 | $2.59M | Buy |
239,232
+51,804
| +28% | +$561K | ﹤0.01% | 2949 |
|
|
2016
Q2 | $1.27M | Buy |
187,428
+11,292
| +6% | +$76.5K | ﹤0.01% | 3218 |
|
|
2016
Q1 | $821K | Sell |
176,136
-17,520
| -9% | -$81.7K | ﹤0.01% | 3322 |
|
|
2015
Q4 | $1.22M | Buy |
193,656
+17,360
| +10% | +$110K | ﹤0.01% | 3268 |
|
|
2015
Q3 | $1.56M | Buy |
176,296
+47,344
| +37% | +$418K | ﹤0.01% | 3194 |
|
|
2015
Q2 | $1.52M | Sell |
128,952
-11,055
| -8% | -$130K | ﹤0.01% | 3219 |
|
|
2015
Q1 | $2.03M | Buy |
140,007
+36,376
| +35% | +$526K | ﹤0.01% | 3102 |
|
|
2014
Q4 | $1.77M | Sell |
103,631
-3,111
| -3% | -$53.1K | ﹤0.01% | 3155 |
|
|
2014
Q3 | $1.33M | Sell |
106,742
-18,604
| -15% | -$232K | ﹤0.01% | 3221 |
|
|
2014
Q2 | $1.84M | Buy |
125,346
+9,523
| +8% | +$140K | ﹤0.01% | 3215 |
|
|
2014
Q1 | $2.36M | Buy |
115,823
+2,000
| +2% | +$40.7K | ﹤0.01% | 3093 |
|
|
2013
Q4 | $2.23M | Buy |
113,823
+3,885
| +4% | +$76.1K | ﹤0.01% | 3114 |
|
|
2013
Q3 | $4.98M | Buy |
109,938
+10,639
| +11% | +$482K | ﹤0.01% | 2732 |
|
|
2013
Q2 | $2.37M | Buy |
+99,299
| New | +$2.37M | ﹤0.01% | 3002 |
|